These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 2830618)

  • 1. Stabilization of type I topoisomerase-DNA covalent complexes by actinomycin D.
    Trask DK; Muller MT
    Proc Natl Acad Sci U S A; 1988 Mar; 85(5):1417-21. PubMed ID: 2830618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topoisomerase I cleavage sites identified and mapped in the chromatin of Dictyostelium ribosomal RNA genes.
    Ness PJ; Koller T; Thoma F
    J Mol Biol; 1988 Mar; 200(1):127-39. PubMed ID: 2837575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of ribosomal RNA synthesis in a gene dosage mutant: the relationship of topoisomerase I and chromatin structure to transcriptional activity.
    Muscarella DE; Vogt VM; Bloom SE
    J Cell Biol; 1987 Oct; 105(4):1501-13. PubMed ID: 2822724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct effects of topoisomerase I and RNA polymerase I inhibitors suggest a dual mechanism of nucleolar/nucleoplasmic partitioning of topoisomerase I.
    Christensen MO; Krokowski RM; Barthelmes HU; Hock R; Boege F; Mielke C
    J Biol Chem; 2004 May; 279(21):21873-82. PubMed ID: 15014084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of morpholinyl doxorubicins, doxorubicin, and actinomycin D on mammalian DNA topoisomerases I and II.
    Wassermann K; Markovits J; Jaxel C; Capranico G; Kohn KW; Pommier Y
    Mol Pharmacol; 1990 Jul; 38(1):38-45. PubMed ID: 2164630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redistribution of ribosomal DNA after blocking of transcription induced by actinomycin D.
    Schöfer C; Weipoltshammer K; Almeder M; Müller M; Wachtler F
    Chromosome Res; 1996 Aug; 4(5):384-91. PubMed ID: 8871827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of gene-specific lesions, DNA-replication-associated damage, and subsequent transcriptional inhibition in topoisomerase inhibitor-mediated apoptosis in lymphoma cells.
    Muscarella DE; Rachlinski MK; Sotiriadis J; Bloom SE
    Exp Cell Res; 1998 Jan; 238(1):155-67. PubMed ID: 9457068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific in vivo cleavages by DNA topoisomerase I in the regulatory regions of the 35 S rRNA in Saccharomyces cerevisiae are transcription independent.
    Vogelauer M; Camilloni G
    J Mol Biol; 1999 Oct; 293(1):19-28. PubMed ID: 10512712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleolar localization of the human telomeric repeat binding factor 2 (TRF2).
    Zhang S; Hemmerich P; Grosse F
    J Cell Sci; 2004 Aug; 117(Pt 17):3935-45. PubMed ID: 15265990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes.
    Zhang H; Wang JC; Liu LF
    Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1060-4. PubMed ID: 2829214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence specificity of DNA topoisomerase I in the presence and absence of camptothecin.
    Thomsen B; Mollerup S; Bonven BJ; Frank R; Blöcker H; Nielsen OF; Westergaard O
    EMBO J; 1987 Jun; 6(6):1817-23. PubMed ID: 3038537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topoisomerase-II-mediated DNA cleavage within the human ribosomal genes.
    Govoni M; Neri S; Labella T; Sylvester JE; Novello F; Pession A
    Biochem Biophys Res Commun; 1995 Aug; 213(1):282-8. PubMed ID: 7639746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eukaryotic type I topoisomerase is enriched in the nucleolus and catalytically active on ribosomal DNA.
    Muller MT; Pfund WP; Mehta VB; Trask DK
    EMBO J; 1985 May; 4(5):1237-43. PubMed ID: 2988941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo sequencing of camptothecin-induced topoisomerase I cleavage sites in human colon carcinoma cells.
    Pondarré C; Strumberg D; Fujimori A; Torres-León R; Pommier Y
    Nucleic Acids Res; 1997 Oct; 25(20):4111-6. PubMed ID: 9321666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Camptothecin-induced in vivo topoisomerase I cleavages in the transcriptionally active tyrosine aminotransferase gene.
    Stewart AF; Schütz G
    Cell; 1987 Sep; 50(7):1109-17. PubMed ID: 2887294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Camptothecin-stabilized topoisomerase I-DNA adducts cause premature termination of transcription.
    Bendixen C; Thomsen B; Alsner J; Westergaard O
    Biochemistry; 1990 Jun; 29(23):5613-9. PubMed ID: 1696837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topoisomerase I interaction with SV40 DNA in the presence and absence of camptothecin.
    Jaxel C; Kohn KW; Pommier Y
    Nucleic Acids Res; 1988 Dec; 16(23):11157-70. PubMed ID: 2849758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A site and strand specific nuclease activity with analogies to topoisomerase I frames the rRNA gene of Tetrahymena.
    Gocke E; Bonven BJ; Westergaard O
    Nucleic Acids Res; 1983 Nov; 11(22):7661-78. PubMed ID: 6316268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topoisomerase I is associated with the regulatory region of transcriptionally active SV 40 minichromosomes.
    Vassetzky YS; Bakayev VV; Kalandadze AG; Razin SV
    Mol Cell Biochem; 1990 Jun; 95(2):95-106. PubMed ID: 1694956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of DNA topoisomerase I in the transcription of supercoiled rRNA gene.
    Garg LC; DiAngelo S; Jacob ST
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3185-8. PubMed ID: 3033639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.